Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by fredgoodwinsonon Mar 24, 2021 5:32am
331 Views
Post# 32864518

Does anyone else

Does anyone else

...get the sense that we’re going nowhere again?

 

The 31.5 cent with support balloon has been well and truly burst and we’re back in the mid 20`s with a very thin buy side. Seems more than just the circular manipulation that has plagued the stock for so long - feels instead as if it has run out of steam. Will be interesting to see how this correlates with the critical 90 day results for 13 & 14 that should already have been published when they eventually are.

 

In the meantime the last Quarterly began kicking Rutherrin down the road - possibly into infinity - and the opportunity to establish a relationship with Roswell/Lumeda looks to have passed.

 

Competitors have made much progress in the age since Rutherrin was first announced but thanks to the work of Prof. Lilge and his colleagues Sherri`s legacy may not be squandered and the rights to her compounds that Theralase are lucky enough to own eventually still amount to something well in excess of the current sp.

 

Hold for the IP - above all the Osmium.

 
<< Previous
Bullboard Posts
Next >>